Palo Alto Investors
Palo Alto Investors is an investment advisor founded in 1989 with $1.5 billion under management. The firm's approach is deeply fundamental and their goal is to serve clients by delivering sustained, high rates of return over time. The firm offers several strategies, each of which has the same basic approach and goal, but focus on different market segments.
The firm's investment focus is predominantly Micro-Cap & Small-Cap U.S. Equities and sectors include Technology, Healthcare, Energy, Consumer, & Financial Services.
View Older Stories View More Recent Stories
-
Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A STAAR SURGICAL CO Filed by: Palo Alto Investors, LLC
-
Form 13F-HR Palo Alto Investors, For: Dec 31
-
Form SC 13G/A AMAG PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form 13F-HR Palo Alto Investors, For: Sep 30
-
Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors, LLC
-
Form 13F-HR Palo Alto Investors, For: Jun 30
-
Form 13F-HR Palo Alto Investors, For: Mar 31
-
GoldMining Initiates Technical Advisory Board with First Appointments of Paul Zweng, PhD, Ross Sherlock, PhD and Curtis Clarke, BSc (Mining Engineering)
-
Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors, LLC
-
Form 13F-HR Palo Alto Investors, For: Dec 31
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A STAAR SURGICAL CO Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A SEQUENOM INC Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A AMAG PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A ABIOMED INC Filed by: Palo Alto Investors, LLC
-
Form 13F-HR Palo Alto Investors, For: Sep 30
-
City of Scottsdale Highlights Companies Breaking New Ground on the Scottsdale Cure Corridor
-
Form 13F-HR/A Palo Alto Investors, For: Jun 30
-
Form 13F-HR Palo Alto Investors, For: Jun 30
-
Form 13F-HR Palo Alto Investors, For: Mar 31
-
Official Team Roster Announced In The $1M Palo Alto Prize
-
Rare Disease Legislative Advocates to Convene Panel of Patient Advocates & Biomedical Innovators for Congressional Briefing on Rare Diseases Ecosystem on March 3
-
Form 13F-HR Palo Alto Investors, For: Dec 31
-
Form SC 13G Karyopharm Therapeutics Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A AUXILIUM PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Celladon Corp Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Anacor Pharmaceuticals, Filed by: Palo Alto Investors, LLC
-
Form SC 13G SUNESIS PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A RIGEL PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G Epizyme, Inc. Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A STAAR SURGICAL CO Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A CYBERONICS INC Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A ABIOMED INC Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A AMAG PHARMACEUTICALS Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A SEQUENOM INC Filed by: Palo Alto Investors, LLC
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors, LLC
